Literature DB >> 25484064

Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.

Christine J Rossant1, Danielle Carroll, Ling Huang, John Elvin, Frances Neal, Edward Walker, Joris J Benschop, Eldar E Kim, Simon T Barry, Tristan J Vaughan.   

Abstract

Generation of functional antibodies against integral membrane proteins such as the G-protein coupled receptor CXCR2 is technically challenging for several reasons, including limited epitope accessibility, the requirement for a lipid environment to maintain structure and their existence in dynamic conformational states. Antibodies to human CXCR2 were generated by immunization in vivo and by in vitro selection methods. Whole cell immunization of transgenic mice and screening of phage display libraries using CXCR2 magnetic proteoliposomes resulted in the isolation of antibodies with distinct modes of action. The hybridoma-derived antibody fully inhibited IL-8 and Gro-α responses in calcium flux and β-arrestin recruitment assays. The phage-display derived antibodies were allosteric antagonists that showed ligand dependent differences in functional assays. The hybridoma and phage display antibodies did not cross-compete in epitope competition assays and mapping using linear and CLIPS peptides confirmed that they recognized distinct epitopes of human CXCR2. This illustrates the benefits of using parallel antibody isolation approaches with different antigen presentation methods to successfully generate functionally and mechanistically diverse antagonistic antibodies to human CXCR2. The method is likely to be broadly applicable to other complex membrane proteins.

Entities:  

Keywords:  BSA, bovine serum albumin; CDR, complementarity determining region; CXCR2; CXCR2, C-X-C Chemokine Receptor 2; ECL, extracellular loops; ENA-78, epithelial derived -neutrophil activating protein; FBS, fetal bovine serum; FMAT, Fluorescence Microvolume Assay Technology; GCP-2, granulocyte activating protein; GPCR; GPCR, G-protein coupled receptor; Gro-α, growth related oncogene- α; Gro-β, growth related oncogene- β; Gro-γ, growth related oncogene- γ; IL-8, Interleukin-8; Ig, Immunoglobulin; NAP-2, neutrophil activating protein-2, CLIPS, Chemical Linkage of Peptides onto Scaffolds; PBS, phosphate buffered saline; epitope mapping; human antibody; immunization; phage display; proteoliposomes; scFv, single chain Fv fragments

Mesh:

Substances:

Year:  2014        PMID: 25484064      PMCID: PMC4622561          DOI: 10.4161/mabs.34376

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  80 in total

1.  Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge.

Authors:  Shogo Misumi; Daisuke Nakayama; Masashi Kusaba; Takaaki Iiboshi; Ryouzaburo Mukai; Kuniomi Tachibana; Tadashi Nakasone; Mamoru Umeda; Hideaki Shibata; Masafumi Endo; Nobutoki Takamune; Shozo Shoji
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 3.  New advances in production and functional folding of G-protein-coupled receptors.

Authors:  Jean-Louis Banères; Jean-Luc Popot; Bernard Mouillac
Journal:  Trends Biotechnol       Date:  2011-04-16       Impact factor: 19.536

Review 4.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

5.  Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.

Authors:  Catherine Murphy; Maryalice McGurk; Johanna Pettigrew; Alfredo Santinelli; Roberta Mazzucchelli; Patrick G Johnston; Rodolfo Montironi; David J J Waugh
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

6.  MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.

Authors:  Sandra Kraemer; Hongqi Lue; Alma Zernecke; Aphrodite Kapurniotu; Erika Andreetto; Ronald Frank; Birgitt Lennartz; Christian Weber; Jürgen Bernhagen
Journal:  FASEB J       Date:  2010-11-24       Impact factor: 5.191

7.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

Authors:  Yusheng Qiu; Jie Zhu; Venkata Bandi; Robert L Atmar; Keith Hattotuwa; Kay K Guntupalli; Peter K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  2003-07-11       Impact factor: 21.405

Review 8.  Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression.

Authors:  J Luan; R Shattuck-Brandt; H Haghnegahdar; J D Owen; R Strieter; M Burdick; C Nirodi; D Beauchamp; K N Johnson; A Richmond
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

9.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.

Authors:  S K Ahuja; J C Lee; P M Murphy
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

View more
  11 in total

Review 1.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

2.  Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challenges.

Authors:  Mohammed Akli Ayoub; Pascale Crépieux; Markus Koglin; Marc Parmentier; Jean-Philippe Pin; Anne Poupon; Eric Reiter; Martine Smit; Jan Steyaert; Hervé Watier; Trevor Wilkinson
Journal:  MAbs       Date:  2017-05-05       Impact factor: 5.857

3.  DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops.

Authors:  Bas van der Woning; Gitte De Boeck; Christophe Blanchetot; Vladimir Bobkov; Alex Klarenbeek; Michael Saunders; Magali Waelbroeck; Toon Laeremans; Jan Steyaert; Anna Hultberg; Hans De Haard
Journal:  MAbs       Date:  2016-05-21       Impact factor: 5.857

4.  Selection of a picomolar antibody that targets CXCR2-mediated neutrophil activation and alleviates EAE symptoms.

Authors:  Xiaojie Shi; Yue Wan; Nan Wang; Jiangchao Xiang; Tao Wang; Xiaofeng Yang; Ju Wang; Xuxue Dong; Liang Dong; Lei Yan; Yu Li; Lili Liu; Shinchen Hou; Zhenwei Zhong; Ian A Wilson; Bei Yang; Guang Yang; Richard A Lerner
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 14.919

Review 5.  Phage display-derived human antibodies in clinical development and therapy.

Authors:  André Frenzel; Thomas Schirrmann; Michael Hust
Journal:  MAbs       Date:  2016-07-14       Impact factor: 5.857

6.  Capture and display of antibodies secreted by hybridoma cells enables fluorescent on-cell screening.

Authors:  Rama Devudu Puligedda; Rashmi Sharma; Fetweh H Al-Saleem; Diana Kouiavskaia; Arul Balaji Velu; Chandana Devi Kattala; George C Prendergast; David R Lynch; Konstantin Chumakov; Scott K Dessain
Journal:  MAbs       Date:  2019-02-22       Impact factor: 5.857

7.  Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies.

Authors:  Martin J Scott; Amanda Jowett; Martin Orecchia; Peter Ertl; Larissa Ouro-Gnao; Julia Ticehurst; David Gower; John Yates; Katie Poulton; Carol Harris; Michael J Mullin; Kathrine J Smith; Alan P Lewis; Nick Barton; Michael L Washburn; Ruud de Wildt
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

8.  Structure-guided discovery of a single-domain antibody agonist against human apelin receptor.

Authors:  Yanbin Ma; Yao Ding; Xianqiang Song; Xiaochuan Ma; Xun Li; Ning Zhang; Yunpeng Song; Yaping Sun; Yuqing Shen; Wenge Zhong; Liaoyuan A Hu; Yingli Ma; Mei-Yun Zhang
Journal:  Sci Adv       Date:  2020-01-15       Impact factor: 14.136

9.  Therapeutic blockade of CXCR2 rapidly clears inflammation in arthritis and atopic dermatitis models: demonstration with surrogate and humanized antibodies.

Authors:  Md Jahangir Alam; Liang Xie; Caroline Ang; Farnaz Fahimi; Stephen B Willingham; Andrew J Kueh; Marco J Herold; Charles R Mackay; Remy Robert
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

10.  A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.

Authors:  Francesco Nannini; Farhaan Parekh; Patrycja Wawrzyniecka; Leila Mekkaoui; Matteo Righi; Fatemeh V Dastjerdi; Jenny Yeung; Claire Roddie; Yuchen Bai; Biao Ma; Mathieu Ferrari; Shimobi Onuoha; Kerry Chester; Martin Pule
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.